InterCure Ltd., together with its subsidiaries, engages in the production, manufacturing, and distribution of pharmaceutical-grade cannabis and cannabis-based products for medical use in Israel and internationally. The company offers dried cannabis inflorescences and cannabis extract mixed with oil. It also invests in …
| Periodo | 2023-08 | 2023-05 | 2023-03 | 2022-11 |
|---|---|---|---|---|
| Real | $0.03 | — | $0.11 | $0.04 |
| Estimado | $0.01 | $0.01 | $0.05 | $0.08 |
| Sorpresa | +200.0% | — | +120.0% | -50.0% |
| Métrica | INCR | Mediana Sector | Δ |
|---|---|---|---|
| Gross Margin | 12.7% | 57.4% | -44.7% |
| Operating Margin | -28.1% | -34.4% | +6.2% |
| Net Margin | -28.4% | -32.5% | +4.1% |
| FCF Margin | -29.9% | -12.6% | -17.3% |
| ROE | -17.1% | -39.2% | +22.1% |
| ROA | -8.9% | -30.9% | +22.1% |
| Current Ratio | 1.73 | 2.73 | -1.00 |
| Debt / Equity | 0.29 | 0.28 | +0.01 |
| Tendencia (Piotroski) | FY24 | FY23 |
|---|---|---|
| ✗Rentabilidad sobre activos positiva | -8.9% | — |
| ✗Flujo de caja operativo positivo | −₪67M | −₪54M |
| ✗Rentabilidad sobre activos al alza | -8.9% | -7.9% |
| ✓Caja operativa/activos supera al ROA | -8.8% | ROA -8.9% |
| ✗Menos deuda a largo plazo | 14.9% | 10.5% |
| ✗Mejor liquidez (ratio corriente) | 1.73 | 1.85 |
| ✗Sin aumentar el nº de acciones | 46M | 46M |
| ✗Margen bruto al alza | 12.7% | 29.6% |
| ✗Rotación de activos al alza | 0.31 | 0.45 |
| Calidad del negocio | FY24 |
|---|---|
| ✗Margen FCF > 10 % | -29.9% |
| ✗ROCE > 10 % | -12.5% |
| ✗Ventas > 5 %/año (3 años) | 2.8% |
| ✓Deuda neta/EBITDA < 3x | -2.0x |
| ✗Reinversión (I+D + capex) > 3 % de ventas | 2.0% |
Intercure Ltd. cotiza a 4.57 USD y tiene una capitalización bursátil de $69M. Datos fundamentales de la SEC EDGAR con hasta 20 años de histórico, insiders, institucionales y valoración DCF.Más empresas del sector Salud